NCT03975413View on ClinicalTrials.gov

Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

May 1, 2020

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
OTHER

Fecal Microbiota Transplantation (FMT)

Longitudinal FMT study: Baseline, 3 week, 13 week, 26 week, 39 week, 52 week

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT03975413 - Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis | Biotech Hunter | Biotech Hunter